Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication May 8, 2019
- Accepted for publication August 21, 2019
- Published online April 1, 2020.
Article Versions
- previous version (October 4, 2019 - 13:09).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Neeta Pandit-Taskar1–3,
- Michael A. Postow4,5,
- Matthew D. Hellmann3–5,
- James J. Harding4,5,
- Christopher A. Barker6,
- Joseph A. O’Donoghue7,
- Martha Ziolkowska1,
- Shutian Ruan1,2,
- Serge K. Lyashchenko8,9,
- Frank Tsai10,
- Michael Farwell11,
- Tara C. Mitchell11,
- Ron Korn12,
- William Le13,
- Jason S. Lewis1,8,9,
- Wolfgang A. Weber1,
- Deepak Behera13,
- Ian Wilson13,
- Michael Gordon10,
- Anna M. Wu13,14 and
- Jedd D. Wolchok3–5
- 1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
- 2Department of Radiology, Weill Cornell Medical College, New York, New York
- 3Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York
- 4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
- 5Department of Medicine, Weill Cornell Medical College, New York, New York
- 6Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
- 7Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
- 8Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York
- 9Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, New York, New York
- 10Honor Health, Scottsdale, Arizona
- 11University of Pennsylvania, Philadelphia, Pennsylvania
- 12Imaging Endpoints, Scottsdale, Arizona
- 13ImaginAb, Inc., Inglewood, California; and
- 14Department of Molecular Imaging and Therapy, Beckman Research Institute of the City of Hope, Duarte, California
- For correspondence or reprints contact: Neeta Pandit-Taskar, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY 10065. E-mail: pandit-n{at}mskcc.org
Statistics from Altmetric.com
Cited By...
Article usage
First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Jump to section
Related Articles
Cited By...
- Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
- Multiparametric MRI of Early Tumor Response to Immune Checkpoint Blockade in Metastatic Melanoma
- Imaging of T-cell Responses in the Context of Cancer Immunotherapy
- Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET
- Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer: Results from a Prospective Imaging Trial
- ICAM-1 orchestrates the abscopal effect of tumor radiotherapy
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
- Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 2: The Role of Novel PET Agents
- Quo Vadis, Molecular Imaging?
- Can Molecular Imaging Measure T-cell Activation?
- The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment